Clinical trial
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell…
NCT00376480 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00376480 |
|---|---|
| Title | Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant |
| Official title | Delayed Infusion of Ex Vivo Anergized Peripheral Blood Mononuclear Cells Following CD34 Selected Peripheral Blood Stem Cell Transplantation From a Haploidentical Donor for Patients With Acute Leukemia and Myelodysplasia |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH National Institute of Allergy and Infectious Diseases (NIAID) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, peripheral blood lymphocyte therapy, fludarabine phosphate, methylprednisolone, thiotepa, allogeneic hematopoietic stem cell transplantation, in vitro-treated peripheral blood stem cell transplantation, total-body irradiation |
| Enrollment | 19 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | May 16, 2018 |
| First posted | Sep 15, 2006 |
| Last update posted | Jul 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: